SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-23-006641
Filing Date
2023-07-20
Accepted
2023-07-20 17:17:20
Documents
2
Period of Report
2023-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1769
2 POWER OF ATTORNEY yuwayechupoa.htm EX-24.1 7603
  Complete submission text file 0001567619-23-006641.txt   10756
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT STE 200 SAN DIEGO CA 92121
Business Address
Chu Yu-Waye (Reporting) CIK: 0001854586 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37587 | Film No.: 231100537